FDANews
FDAnews Device Daily Bulletin

Pinnacle Spine Group Receives a Fourth Patent for Graft Device

July 13, 2017

Pinnacle Spine Group received a U.S. patent for its in situ graft delivery technology, the company announced.

The patent applies to the company’s system for delivery of graft material to the chamber of a spinal fusion device. The company has previously received three patents covering the same fusion technology and owns several non-U.S. applications, including in Europe, Australia and Canada.

The devices hinge on targeted in situ placement of bone graft material directly into the implanted device for maximum contact with the vertebral endplates.

View today's stories